A man in a laboratory looking into a microscope

Search Studies

Research studies are looking for volunteers just like you. Both healthy volunteers and participants with specific health conditions are needed to help answer important questions impacting the health of our friends and family. Join us to improve the health of others.

* indicates required field
Found 100 results. Displaying page 1 of 9.
  • Evaluating the Efficacy of a Psychedelic Investigational Drug for Patients who are Struggling with Symptoms of Depression and Anxiety due to Cancer or Other Life-Changing Medical Illness

    Official Title A Randomized, Double-Blind, Parallel-Group, Dose-Controlled Study Evaluating the Safety and Efficacy of RE104 for Injection in the Treatment of Adjustment Disorder in Patients with Cancer and Other Medical Illnesses

    Purpose

    The purpose of this study is to determine if treatment with a single dose of RE104 for Injection reduces depressive symptoms or depressive symptoms mixed with anxiety symptoms in participants with Adjustment Disorder due to cancer or other illnesses such as Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), Parkinson's Disease (PD) or Idiopathic Pulmonary Fibrosis (IPF) as compared to active-placebo.

    Could this study be right for you?

    • Depression due to cancer, Parkinson’s, ALS, MS, or IPF
    • Currently depressed
    • Projected life expectancy of ≥6 months.

    Age Range

    18 - 80 years

    Contact Information

    Harding Hospital
    Gilles Fontgalland
    614-293-7109
  • Evaluating the Safety and Efficacy of Icalcaprant in the Treatment of Subjects with Major Depressive Disorder (MDD)

    Official Title A Phase 2, Multicenter, 6-Week, Double Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Icalcaprant in Subjects with Major Depressive Disorder

    Purpose

    Major depressive disorder (MDD; depression) is a mood disorder that causes a continued feeling of sadness and loss of interest. It is a common and serious illness that can cause both emotional and physical symptoms such as feelings of sadness, irritability, not being able to focus on activities, tiredness, changes in eating habits, and aches and pains.

    This study will assess the changes in disease activity and adverse events of oral Icalcaprant in adult participants with major depressive disorder who are currently experiencing a major depressive episode (MDE).

    Could this study be right for you?

    • Diagnosed with MDD
    • Current major depressive episode
    • Willing to discontinue antidepressant treatments

    Age Range

    18 - 65 years

    Contact Information

    Harding Hospital
    Megan Whipple
    614-685-1605
  • Evaluating the Efficacy and Safety of Icalcaprant in Subjects with Bipolar Depression

    Official Title A Phase 2, Multicenter, 6-Week, Double Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Icalcaprant in Subjects with Bipolar Depression

    Purpose

    Bipolar disorder is a severe chronic mood disorder that affects up to 4% of the adult population.This study will assess how safe and effective Icalcaprant is in treating adult participants with bipolar I or II disorder.

    Could this study be right for you?

    • Diagnosed with Bipolar Disorder I or II
    • Currently in a depressive episode
    • Currently receiving treatment of a mood stabilizer

    Age Range

    18 - 65 years

    Contact Information

    Harding Hospital
    Meredith Roach
    614-293-3449
  • Research Study for Grave's Disease

    Official Title A Phase 1, First-in-Human, Placebo-Controlled, Single and Multiple Ascending Dose Study to Evaluate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Intravenous and Subcutaneous Administration of MER511 in Adults With Graves’ Disease

    Purpose

    1. To find out how safe the study drug is and how well people with Graves’ disease can handle taking one or more doses.

    2. To describe how the body absorbs, uses, and removes a single IV or subcutaneous dose, or several subcutaneous doses, of MER511 in people with Graves’ disease.

    3. To check whether the body creates an immune response after a single IV or subcutaneous dose, or several subcutaneous doses, of MER511 in people with Graves’ disease.

     

    Could this study be right for you?

    1. Grave's disease diagnosis

    2. Taking methimazole or propylthiouracil

    3. Weigh at least 110 lbs

    4. Women of childbearing potential must agree to use contraceptive methods and avoid egg donation during the study; Men with partners of childbearing potential must agree to use a condom or abstinence and avoid sperm donation during the study

    Age Range

    18 - 55 years

    Contact Information

    Ohio State University Carepoint East
    Lindsey Aldrich
    614-814-0772
  • Men’s Health, Friendships and Relationships

    Official Title Men Talking: How Do Men Discuss Health, Friendships, and Relationships?

    Purpose

    The purpose of this study is to gain a better understanding of men’s friendships, relationships, and health-information seeking.

    The study consists of a 60–90-minute interview at a location of the participant’s choosing.

    Thank you for your time and assistance!

    Could this study be right for you?

    • 18 years and older 
    • assigned male at birth
    • live in Columbus Metro Area

    Age Range

    18 years and up

    Contact Information

    Columbus metro area, OH
    Men Talking Study Team
    (614) 642-8663
  • Kicking the Habit: A Research Study Testing the Buckeye Quit Stick

    Official Title A Pilot/Feasibility Study of the Buckeye Quit Stick: A Novel Resource for Successful Tobacco Cessation

    Purpose

    The Buckeye Quit Stick is part of a research study to learn whether people are willing to use a handheld stick as a tool for the hand-mouth routine of smoking. It focuses on the hand-to-mouth habit by providing something to hold and use instead of a cigarette. The main goal of this study is to see if patients that plan to quit smoking will use this device and evaluate their experiences with the Buckeye Quit Stick.

    Participants will also continue to receive national guidelines for smoking cessation support from the James Comprehensive Cancer Center Smoking Cessation Clinic. A participant is considered to have completed the research study when they complete all study visits or at approximately 6 months.

    Could this study be right for you?

    • Must be 21 years of age or older
    • Patient of the OSU Thoracic Clinics
    • Suspected or confirmed lung cancer diagnosis
    • Current self-reported smoker

    Age Range

    21 years and up

    Contact Information

    Columbus, OH
    Thoracic Non-Therapeutic Research Team
    614-814-6550
  • Preserving Manual Wheelchair User Shoulder Health

    Official Title Quantifying Musculoskeletal Adaptations to Manual Wheelchair Use Across the Lifespan

    Purpose

    Manual wheelchair use places high physical demands on the arms and shoulders, which can lead to pain and injury, especially with aging. This study aims to understand how wheelchair use affects shoulder anatomy and movement to improve prevention, early detection, and treatment of upper extremity pain and injury in manual wheelchair users.

    Participation includes two in-person research sessions, each lasting about 60 minutes, conducted at the Martha Morehouse Medical Pavilion:

    • MRI session to examine shoulder anatomy (no radiation involved)
    • Movement analysis session to assess muscle activity and arm function during everyday tasks such as wheelchair propulsion and reaching

    Sessions may be completed on the same day or on different days within one week.

    Total study participation is approximately 2 hours.

    Could this study be right for you?

    • Adults (>18 years old) who are primary manual wheelchair users
    • Must be able to safely participate in MRI and movement analysis
    • Individuals who are pregnant or have MRI-incompatible metal implants are not eligible

    Age Range

    18 - 110 years

    Contact Information

    Martha Morehouse Medical Plaza
    Wheelchair User Shoulder Health (WUSH) Study Team
  • Participate in an Eight-week Online Mind-body Research Intervention for Brain Health

    Official Title Internet-based Mind-Body Training (iMBT) for Brain Health

    Purpose

    The Clinical Neuroscience Laboratory is looking for male volunteers (ages 50 years and older) with cognitive concerns to participate in an online eight-week mind-body research intervention for promoting brain health.

    Participation will involve web-based, phone-based, and in-person assessment sessions. Assessment sessions will include a blood draw, neuropsychological assessments, MRI scan, and Fitbit tracking followed by the eight-week online internet-based mind-body intervention where participants are invited to complete one 2.5 hour session per week at their own pace.

    Could this study be right for you?

    1. At least 50 years old and concerned about your memory or attention?
    2. Fluent in English?
    3. Do you have access to WiFi at home?
    4. Never diagnosed with mild cognitive impairment or dementia?
    5. Live in the Greater Columbus Metropolitan area?
    6. Willing to commit to a virtual research intervention and in-person assessments?

    Age Range

    50 years and up

    Contact Information

    1835 Neil Ave, Columbus OH 43210
    Angie Cordova
    614-292-9568
  • CP-MOVES: Standing Intervention for Children with Motor Delays.

    Official Title CP-MOVES: Complex rehabilitation technology enabled Physical activity for children with Motor delays Via telehealth in natural Environments

    Purpose

    This study will examine physical activity, sleep, and quality of life in children with severe motor delays and their parents before and after an 8-week intervention using adaptive standers.

    Parents with a child with severe motor delay will enroll with their child (up to 1 parent per child). Both parent and child will participate in one telehealth-supervised session per week and two unsupervised sessions per week. Both parent and child will wear activity trackers on the wrists and waist for 1 week before and 1 week after treatment in order to measure physical activity and sleep. Parents will also complete surveys on quality of life before and after treatment. 

    Could this study be right for you?

    • Medical diagnosis causing motor delay 
    • Unable to stand independently 
    • A parent or primary caregiver able to enroll as a participant in the study 
    • Internet or cellular service to join telehealth sessions  
    • Live within 100 miles of Ohio State University or willing to travel to the lab for one visit 

    Age Range

    1 - 6 years

    Contact Information

    Martha Morehouse Pavilion and Remote
    Petra Sternberg
    614-572-5446
  • Living Well with Advanced Breast Cancer

    Official Title Living Well with Advanced Breast Cancer

    Purpose

    The purpose of this study is to understand how patients with advanced breast cancer are using supportive care, what has helped them, what has been hard, and what kind of help they still need. Our goal is to learn from patients and caregivers about met and unmet survivorship care needs, including care that focuses on improving health and well-being of a person living with cancer.

    Study participants would be asked to complete a brief survey on their demographics via phone or email. Participants will then complete a one-time interview with our study staff via zoom, phone call, or in person, depending on preference. During the interview, the study team will ask for feedback on patient and caregiver experience and needs regarding support services.

    Total study participation is less than 2 hours and can be done remotely.

    Could this study be right for you?

    • Diagnosed with stage 4 metastatic breast cancer within the past 5 years
    • A patient in the Medical Oncology Clinic at Stephanie Spielman Comprehensive Breast Center (SSCBC)

     

    Age Range

    18 - 110 years

    Contact Information

    Columbus, OH
    Breast Non-Therapeutic Research Team
    614-814-1284
  • TBI and other Acquired Brain Injuries Study

    Official Title Resource Mapping for Families of Children with Brain Injury

    Purpose

    The purpose of this study is to assess the family needs of children with a brain injury. We want to explore your experiences getting care, the barriers, and facilitators your family has faced in navigating and accessing services after hospital discharge, and your ongoing unmet needs.

    Could this study be right for you?

    • You are a primary care giver of a child that sustained a brain injury
    • Your child was hospitalized for an overnight stay as a result of their brain injury
    • Your child was 18 or younger when their brain injury occurred
    • You speak English 

    Age Range

    19 years and up

    Contact Information

  • Blocking Orexin Receptors to Help Treat Alcohol Addiction and Stress-Driven Drinking

    Official Title OASIS - Orexin Receptor Antagonism for the Treatment of Alcohol Use Disorder and Stress-Related Drinking

    Purpose

    This study will look at whether suvorexant can help treat alcohol use disorder, how it works, and who it works best for. Suvorexant is a medicine that blocks certain brain signals linked to wakefulness.

     

    Your total participation time in this study will be approximately 9 weeks.

    Could this study be right for you?

    Inclusion Criteria: 

    1. Age 18-65
    2. Participant is able to give informed consent 
    3. Engage in heavy alcohol use defined as drinking ≥14 standard drinks per week if male and ≥7 standard drinks per week if female. 

    General - Exclusion Criteria

    1. Clinically significant medical or neurological condition (e.g., liver disease, narcolepsy, complex sleep behaviors, severe hepatic impairment, COPD, severe obstructive sleep apnea) 
    2. Current or past DSM-5 diagnosis of mania, schizophrenia, psychosis 
    3. Past suicide attempt within 3 years or presence of moderate suicidal ideation
    4. Engage in night-shift work 

     

     

    Age Range

    18 - 65 years

    Contact Information

    Institute for Behavior, Brain, and Immunology at the Ohio State University Wexner Medical Center
    Annabel Fuller
    6143663523